Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Altimeo Asset Management v. WuXi PharmaTech (Cayman) Inc. et al
Case Number:
1:19-cv-01654
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
- Boyu Capital Advisory Co. Ltd.
- Hillhouse Capital Group
- Ping An Insurance
- Sequoia Capital Operations LLC
- WuXi PharmaTech Inc.
Sectors & Industries:
-
October 14, 2020
WuXi PharmaTech Dodges Securities Suit
A New York federal judge tossed a proposed class action Wednesday that alleged pharmaceutical research and development company WuXi PharmaTech misled investors by not disclosing a strategy to spin off three subsidiaries.
-
May 29, 2019
Pomerantz To Lead Securities Suit Against WuXi
Law firm Pomerantz will serve as lead counsel in a proposed class action accusing pharmaceutical research and development company WuXi of keeping investors in the dark about plans to spin off subsidiaries following a merger that took the company private, a New York federal judge has ruled.
-
February 22, 2019
WuXi Accused Of Shorting Investors In Go-Private Deal
A putative class of investors alleged in New York federal court on Thursday that pharmaceutical research and development company WuXi PharmaTech kept them in the dark about plans to spin off subsidiaries following a $3.6 billion merger that took the company private.